Loss of KLF9 facilitates stemness in ovarian cancer ascites-derived multicellular spheroids via Notch1/Slug signaling.
The ascites that develops in advanced ovarian cancer (OC), both at diagnosis and upon recurrence,...
Read More
Hematology/Oncology
Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trial.
Although most patients with epithelial ovarian cancer respond to frontline platinum-based...
Read More
Genetic Testing Proposed for Women Diagnosed With Breast Cancer at Age 65+
FRIDAY, Aug. 6, 2021 (HealthDay News) — Women older than 65 years of age with estrogen...
Read More
Remetinostat Gel Promising for Basal Cell Carcinoma
FRIDAY, Aug. 6, 2021 (HealthDay News) — The histone deacetylase (HDAC) inhibitor...
Read More
All Health Care, Long-Term Care Workers in California Must Get COVID-19 Shots
FRIDAY, Aug. 6, 2021 (HealthDay News) — All 2.2 million health care workers and long-term...
Read More
Smartphone-Only Internet Tied to Lower Patient Portal Use
THURSDAY, Aug. 5, 2021 (HealthDay News) — Smartphone-only internet access is associated with...
Read More
Guidance Issued for Low-Dose Chest CT Screening for Lung Cancer
THURSDAY, Aug. 5, 2021 (HealthDay News) — In a guideline and expert panel report from the...
Read More
Pharmacomechanical Thrombolysis for Acute DVT Tied to Kidney Injury
THURSDAY, Aug. 5, 2021 (HealthDay News) — Use of pharmacomechanical thrombolysis (PMT) for...
Read More
Impact of Surgeon Type and Rurality on Treatment and Survival of Ovarian Cancer Patients.
National Comprehensive Cancer Network guidelines recommend ovarian cancer patients receive...
Read More
Network-guided identification of cancer-selective combinatorial therapies in ovarian cancer.
Each patient’s cancer consists of multiple cell subpopulations that are inherently...
Read More
Development and in vitro characterisation of an induced pluripotent stem cell model of ovarian cancer.
Ovarian cancer recurs despite advances in treatment and is due to drug resistance. The persistence...
Read More
Popular Cancer-Related Social Media Posts Can Contain Misinformation
WEDNESDAY, Aug. 4, 2021 (HealthDay News) — One-third of the most popular cancer treatment...
Read More
Enrollment in Cancer Treatment Trials Largely Unchanged by Pandemic
WEDNESDAY, Aug. 4, 2021 (HealthDay News) — During the COVID-19 pandemic, participation in...
Read More
Certain Dermoscopic Structures Linked to Melanoma Detection
WEDNESDAY, Aug. 4, 2021 (HealthDay News) — Certain dermoscopic structures associated with...
Read More
Women’s Preventive Health Service Use Down in 2020
TUESDAY, Aug. 3, 2021 (HealthDay News) — Women’s use of a range of preventive health...
Read More
Statin Use Improves Survival in Triple-Negative Breast Cancer
TUESDAY, Aug. 3, 2021 (HealthDay News) — For women with triple-negative breast cancer...
Read More
Cancer Screenings Disrupted During Pandemic at Federally Qualified Health Centers
MONDAY, Aug. 2, 2021 (HealthDay News) — The COVID-19 pandemic significantly disrupted...
Read More
Duration of Maintenance Therapy Studied in Childhood ALL
MONDAY, Aug. 2, 2021 (HealthDay News) — For patients with low-risk childhood acute...
Read More
Many Cancer Patients Lack Immunity for Measles, Mumps
MONDAY, Aug. 2, 2021 (HealthDay News) — A considerable proportion of ambulatory patients...
Read More
Ovarian cancer surveillance in the clinical follow up of women with known BRCA1 or BRCA2 pathogenic variants in a large health care system.
To assess CA 125 and transvaginal ultrasound surveillance in women with BRCA1 or BRCA2 pathogenic...
Read More